{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:00:57Z","timestamp":1790395257574,"version":"4.1.0"},"reference-count":45,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1253\/circj.cj-26-0498","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:11:15Z","timestamp":1787868675000},"page":"1389-1397","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular\u2013Kidney\u2013Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data\u3000\u2015 Large-Scale Epidemiological Study \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Yuta","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Department of Advanced Cardiology, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masachika","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Jimba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, St. Luke\u2019s International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Department of Advanced Cardiology, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Azegami","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation<\/i> 2019; 140: e596\u2013e646.","DOI":"10.1161\/CIR.0000000000000725"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. <i>Eur Heart J<\/i> 2021; 42: 3227\u20133337.","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients make sense of health statistics. <i>Psychol Sci Public Interest<\/i> 2007; 8: 53\u201396.","DOI":"10.1111\/j.1539-6053.2008.00033.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, et al. Communicating cardiovascular disease risk: An interview study of general practitioners\u2019 use of absolute risk within tailored communication strategies. <i>BMC Fam Pract<\/i> 2014; 15: 106.","DOI":"10.1186\/1471-2296-15-106"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, et al. General practitioners\u2019 use of different cardiovascular risk assessment strategies: A qualitative study. <i>Med J Aust<\/i> 2013; 199: 485\u2013489.","DOI":"10.5694\/mja13.10133"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. <i>Circulation<\/i> 2008; 117: 743\u2013753.","DOI":"10.1161\/CIRCULATIONAHA.107.699579"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Krishnan V, Huang X, Perak AM, Coresh J, Ndumele CE, Greenland P, et al. PREVENT risk age equations and population distribution in US adults. <i>JAMA Cardiol<\/i> 2025; 10: 962\u2013964.","DOI":"10.1001\/jamacardio.2025.2427"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular\u2013kidney\u2013metabolic health: A presidential advisory from the American Heart Association. <i>Circulation<\/i> 2023; 148: 1606\u20131635.","DOI":"10.1161\/CIR.0000000000001184"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome: A scientific statement from the American Heart Association. <i>Circulation<\/i> 2023; 148: 1636\u20131664.","DOI":"10.1161\/CIR.0000000000001186"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yasunaga H. DeSC database. <i>Ann Clin Epidemiol<\/i> 2025; 7: 46\u201349.","DOI":"10.37737\/ace.25006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Okada A, Yasunaga H. Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people. <i>JMA J<\/i> 2022; 5: 190\u2013198.","DOI":"10.31662\/jmaj.2021-0189"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. <i>Lancet<\/i> 2002; 360: 1903\u20131913.","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. <i>Lancet<\/i> 2010; 375: 2215\u20132222.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. <i>Lancet<\/i> 2011; 377: 1085\u20131095.","DOI":"10.1016\/S0140-6736(11)60105-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. <i>Lancet<\/i> 2010; 375: 2073\u20132081.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: An analysis of burden of disease and life expectancy. <i>Lancet<\/i> 2012; 380: 219\u2013229.","DOI":"10.1016\/S0140-6736(12)61031-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports. <i>BMJ<\/i> 2018; 360: j5855.","DOI":"10.1136\/bmj.j5855"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. <i>Am J Kidney Dis<\/i> 2009; 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kodama S, Saito K, Tanaka S, Horikawa C, Saito A, Heianza Y, et al. Alcohol consumption and risk of atrial fibrillation: A meta-analysis. <i>J Am Coll Cardiol<\/i> 2011; 57: 427\u2013436.","DOI":"10.1016\/j.jacc.2010.08.641"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jennings AC, Rutherford MJ, Lambert PC. A spline-based approach to smoothly constrain hazard ratios with a view to apply treatment effect waning. <i>Stat Med<\/i> 2025; 44: e70035.","DOI":"10.1002\/sim.70035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. <i>Stat Med<\/i> 2002; 21: 2175\u20132197.","DOI":"10.1002\/sim.1203"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pongnikorn D, Phinyo P, Patumanond J, Daoprasert K, Phothong P, Siribumrungwong B. Individualized prediction of breast cancer survival using flexible parametric survival modeling: Analysis of a hospital-based national clinical cancer registry. <i>Cancers (Basel)<\/i> 2021; 13: 1567.","DOI":"10.3390\/cancers13071567"},{"key":"23","unstructured":"23. Lambert P. STPM3: Stata module to fit flexible parametric survival models. Statistical Software Components S459207, Boston College Department of Economics 2023. https:\/\/ideas.repec.org\/c\/boc\/bocode\/s459207.html (accessed July 29, 2026)."},{"key":"24","unstructured":"24. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. <i>BMJ<\/i> 2024; 385: e078378."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakafero G, Grainge MJ, Williams HC, Card T, Taal MW, Aithal GP, et al. Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: Prognostic model development and validation using primary care data from the UK. <i>BMJ<\/i> 2023; 381: e074678.","DOI":"10.1136\/bmj-2022-074678"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Collins GS, Dhiman P, Ma J, Schlussel MM, Archer L, Van Calster B, et al. Evaluation of clinical prediction models (part 1): From development to external validation. <i>BMJ<\/i> 2024; 384: e074819.","DOI":"10.1136\/bmj-2023-074819"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: A framework for traditional and novel measures. <i>Epidemiology<\/i> 2010; 21: 128\u2013138.","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"28","unstructured":"28. Brunelli A. A synopsis of resampling techniques. <i>J Thorac Dis<\/i> 2014; 6: 1879\u20131882."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. McLernon DJ, Giardiello D, Van Calster B, Wynants L, van Geloven N, van Smeden M, et al. Assessing performance and clinical usefulness in prediction models with survival outcomes: Practical guidance for Cox proportional hazards models. <i>Ann Intern Med<\/i> 2023; 176: 105\u2013114.","DOI":"10.7326\/M22-0844"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Royston P, Altman DG. External validation of a Cox prognostic model: Principles and methods. <i>BMC Med Res Methodol<\/i> 2013; 13: 33.","DOI":"10.1186\/1471-2288-13-33"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nakafero G, Card T, Grainge MJ, Williams HC, Taal MW, Aithal GP, et al. Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: Prognostic model development, validation, and, health economic evaluation. <i>EClinicalMedicine<\/i> 2023; 64: 102213.","DOI":"10.1016\/j.eclinm.2023.102213"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Cipolletta E, Nakafero G, Rozza D, Mahil SK, Smith CH, Riley RD, et al. Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: A retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data. <i>Lancet Rheumatol<\/i> 2025; 7: e840\u2013e850.","DOI":"10.1016\/S2665-9913(25)00165-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Abhishek A, Grainge M, Card T, Williams HC, Taal MW, Aithal GP, et al. Risk-stratified monitoring for sulfasalazine toxicity: Prognostic model development and validation. <i>RMD Open<\/i> 2024; 10: e003980.","DOI":"10.1136\/rmdopen-2023-003980"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cooney MT, Vartiainen E, Laatikainen T, De Bacquer D, McGorrian C, Dudina A, et al. Cardiovascular risk age: Concepts and practicalities. <i>Heart<\/i> 2012; 98: 941\u2013946.","DOI":"10.1136\/heartjnl-2011-301478"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: A new method of cardiovascular risk evaluation. <i>Eur Heart J<\/i> 2010; 31: 2351\u20132358.","DOI":"10.1093\/eurheartj\/ehq205"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: The CHECK-UP study: A randomized controlled trial. <i>Arch Intern Med<\/i> 2007; 167: 2296\u20132303.","DOI":"10.1001\/archinte.167.21.2296"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Bonner C, Batcup C, Cornell S, Fajardo MA, Hawkes AL, Trevena L, et al. Interventions using heart age for cardiovascular disease risk communication: Systematic review of psychological, behavioral, and clinical effects. <i>JMIR Cardio<\/i> 2021; 5: e31056.","DOI":"10.2196\/31056"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. B\u00f6rschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases - myocardial infarction and heart failure - a cause for concern. <i>Int J Cardiol<\/i> 2019; 287: 162\u2013173.","DOI":"10.1016\/j.ijcard.2018.11.123"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Acosta S, Du Y, Born\u00e9 Y, Gotts\u00e4ter A. Differences in risk factor profiles for peripheral artery disease compared to coronary, cerebral and carotid artery. <i>Sci Rep<\/i> 2025; 15: 3864.","DOI":"10.1038\/s41598-025-88516-0"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. van den Bogaart M, Snaterse M, van Trier TJ, Peters RJG, Martens FMAC, Boekholdt SM, et al. Differences in long-term impact of traditional risk factors for atherosclerosis on different arterial territories: insights from over 20 years of follow-up in the EPIC-Norfolk prospective population study. <i>Eur J Prev Cardiol<\/i> 2025, doi:10.1093\/eurjpc\/zwaf664.","DOI":"10.1093\/eurjpc\/zwaf664"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Cai J, Yu R, Zhang N, Zhang H, Zhang Y, Xiang Y, et al. Association between cardiovascular biological age and cardiovascular disease: A prospective cohort study. <i>Circ J<\/i> 2025; 89: 620\u2013628.","DOI":"10.1253\/circj.CJ-24-0824"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Medina-Inojosa JR, Somers VK, Garcia M, Thomas RJ, Allison T, Chaudry R, et al. Performance of the ACC\/AHA pooled cohort cardiovascular risk equations in clinical practice. <i>J Am Coll Cardiol<\/i> 2023; 82: 1499\u20131508.","DOI":"10.1016\/j.jacc.2023.07.018"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association\u2019s PREVENT equations. <i>Circulation<\/i> 2024; 149: 430\u2013449.","DOI":"10.1161\/CIRCULATIONAHA.123.067626"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Fujiyoshi A, Kohsaka S, Hata J, Hara M, Kai H, Masuda D, et al. JCS 2023 Guideline on the primary prevention of coronary artery disease. <i>Circ J<\/i> 2024; 88: 763\u2013842.","DOI":"10.1253\/circj.CJ-23-0285"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Okada A, Yamada G, Kimura T, Hagiwara Y, Yamaguchi S, Kurakawa KI, et al. Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic\/glycemic abnormalities. <i>J Diabetes Investig<\/i> 2023; 14: 463\u2013478.","DOI":"10.1111\/jdi.13966"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0498\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:28:14Z","timestamp":1790393294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0498\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0498","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"CJ-26-0498"}}